Literature DB >> 1680493

Multidrug resistance mediated by P-glycoproteins.

A H Schinkel1, P Borst.   

Abstract

Overexpression of P-glycoprotein genes is a well-established cause of one form of multidrug resistance. P-glycoproteins are plasma membrane proteins containing two ATP-binding sites and twelve putative transmembrane segments. P-glycoproteins are thought to act as ATP-dependent drug efflux pumps, actively extruding a range of structurally different, hydrophobic drugs from the cell. This simple model can account for the properties of multidrug resistant cells, even those that seem to require more complex explanations. The structure and function of P-glycoprotein genes has been studied in mammals and in several lower eukaryotes. These studies are helping to delineate the range of drugs that can be transported by P-glycoproteins; the genetic mechanisms that can lead to elevated cellular P-glycoproteins levels; and the evolution of the versatile and prolific P-glycoprotein gene family. The physiological function of the human P-glycoproteins encoded by the MDR1 and MDR3 (or MDR2) genes remains a matter of speculation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1680493

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  26 in total

1.  A potato cDNA encoding a homologue of mammalian multidrug resistant P-glycoprotein.

Authors:  W Wang; D Takezawa; B W Poovaiah
Journal:  Plant Mol Biol       Date:  1996-06       Impact factor: 4.076

Review 2.  The biology of the P-glycoproteins.

Authors:  C R Leveille-Webster; I M Arias
Journal:  J Membr Biol       Date:  1995-01       Impact factor: 1.843

Review 3.  Molecular analysis of the multidrug transporter.

Authors:  U A Germann
Journal:  Cytotechnology       Date:  1993       Impact factor: 2.058

4.  Overexpression of the gene encoding the multidrug resistance-associated protein results in increased ATP-dependent glutathione S-conjugate transport.

Authors:  M Müller; C Meijer; G J Zaman; P Borst; R J Scheper; N H Mulder; E G de Vries; P L Jansen
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

5.  Peripheral neuropathy in mice transgenic for a human MDR3 P-glycoprotein mini-gene.

Authors:  J J Smit; F Baas; J E Hoogendijk; G H Jansen; M A van der Valk; A H Schinkel; A J Berns; D Acton; K Nooter; H Burger; S J Smith; P Borst
Journal:  J Neurosci       Date:  1996-10-15       Impact factor: 6.167

6.  BBB transport and P-glycoprotein functionality using MDR1A (-/-) and wild-type mice. Total brain versus microdialysis concentration profiles of rhodamine-123.

Authors:  E C de Lange; G de Bock; A H Schinkel; A G de Boer; D D Breimer
Journal:  Pharm Res       Date:  1998-11       Impact factor: 4.200

7.  Human brain tumors: multidrug-resistance P-glycoprotein expression in tumor cells and intratumoral capillary endothelial cells.

Authors:  Silvia Fattori; Francesca Becherini; Maurizio Cianfriglia; Giuliano Parenti; Antonella Romanini; Maura Castagna
Journal:  Virchows Arch       Date:  2007-06-26       Impact factor: 4.064

Review 8.  ABC of oral bioavailability: transporters as gatekeepers in the gut.

Authors:  C G Dietrich; A Geier; R P J Oude Elferink
Journal:  Gut       Date:  2003-12       Impact factor: 23.059

Review 9.  Reverse transformation of multidrug-resistant cells.

Authors:  J L Biedler; B A Spengler
Journal:  Cancer Metastasis Rev       Date:  1994-06       Impact factor: 9.264

10.  Caenorhabditis elegans pgp-5 is involved in resistance to bacterial infection and heavy metal and its regulation requires TIR-1 and a p38 map kinase cascade.

Authors:  C Léopold Kurz; Michael Shapira; Karen Chen; David L Baillie; Man-Wah Tan
Journal:  Biochem Biophys Res Commun       Date:  2007-09-12       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.